【The day after Anthropic’s IPO, Morgan Stanley pulled the plug on price support】
On Anthropic’s first day of trading, $ANTB surged to $115.10 before closing at $97.17. The IPO price was $83, so the stock had a respectable debut. But on the second trading day, the share price slid toward the offering price, and Morgan Stanley immediately exercised the full 147 million-share greenshoe option ahead of schedule. The price-stabilization mechanism, which was originally set to last up to 30 days, was over in a single day.
The greenshoe mechanism offers two possible moves: if the share price weakens, underwriters can buy shares on the market to stabilize the price; if it rises above the offering price, they can also buy additional shares directly from the company at $83. Morgan Stanley chose the latter, giving Anthropic about $12.2 billion in additional proceeds—but the market also lost a potential source of buying support.
During Friday’s U.S. trading session (November 20, Eastern Time), ANT closed at $88.91, down 8.5%, after briefly nearing its $83 offering price. The stock is now only about 7% above its IPO price, leaving investors who chased the first-day rally nursing significant losses.
Anthropic’s successful fundraising and record-breaking IPO size don’t guarantee that the stock will find buyers on the secondary market. With the greenshoe option exercised early, $83 will be the level at which the market truly tests demand. If the stock can’t even hold its IPO price, its initial post-listing valuation premium may have further to fall.
#摩根士丹利结束anthropic股价支撑
On Anthropic’s first day of trading, $ANTB surged to $115.10 before closing at $97.17. The IPO price was $83, so the stock had a respectable debut. But on the second trading day, the share price slid toward the offering price, and Morgan Stanley immediately exercised the full 147 million-share greenshoe option ahead of schedule. The price-stabilization mechanism, which was originally set to last up to 30 days, was over in a single day.
The greenshoe mechanism offers two possible moves: if the share price weakens, underwriters can buy shares on the market to stabilize the price; if it rises above the offering price, they can also buy additional shares directly from the company at $83. Morgan Stanley chose the latter, giving Anthropic about $12.2 billion in additional proceeds—but the market also lost a potential source of buying support.
During Friday’s U.S. trading session (November 20, Eastern Time), ANT closed at $88.91, down 8.5%, after briefly nearing its $83 offering price. The stock is now only about 7% above its IPO price, leaving investors who chased the first-day rally nursing significant losses.
Anthropic’s successful fundraising and record-breaking IPO size don’t guarantee that the stock will find buyers on the secondary market. With the greenshoe option exercised early, $83 will be the level at which the market truly tests demand. If the stock can’t even hold its IPO price, its initial post-listing valuation premium may have further to fall.
#摩根士丹利结束anthropic股价支撑